TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,155 | 1,144 | 1,507 |
Financial expenses | 1 | 1 | 0 |
Earnings before taxes | 368 | 282 | 503 |
EBITDA | 343 | 288 | 511 |
Total assets | 1,805 | 1,892 | 2,118 |
Current assets | 1,518 | 1,764 | 1,997 |
Current liabilities | 65 | 94 | 177 |
Equity capital | 1,631 | 1,560 | 1,688 |
- share capital | 50 | 50 | 50 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 90.4% | 82.5% | 79.7% |
Turnover per employee | 1,155 | 1,144 | 1,507 |
Profit as a percentage of turnover | 31.9% | 24.7% | 33.4% |
Return on assets (ROA) | 20.4% | 15.0% | 23.7% |
Current ratio | 2335.4% | 1876.6% | 1128.2% |
Return on equity (ROE) | 22.6% | 18.1% | 29.8% |
Change turnover | 11 | -363 | 34 |
Change turnover % | 1% | -24% | 2% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.